LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 46c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($0.46).

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• TransUnion (TRU) call put ratio 1 call to 4.2 puts with a focus on January 47.50 puts as share price down 9.5%
• Equifax (EFX) call put ratio 1 call to 20 puts with a focus on September 130 and 180 puts as share price down 8.2%